- Some vaccine advisers to the federal government say they’re “disappointed” and “angry” that government scientists and the pharmaceutical company Moderna didn’t present a set of infection data on the company’s new Covid-19 booster during meetings last year when the advisers discussed whether the shot should be authorized and made available to the public.
- That data suggested the possibility that the updated booster might not be any more effective at preventing Covid-19 infections than the original shots.
- The data was early and had many limitations, but several advisers told CNN that they were concerned about a lack of transparency.